YUTIQ® (fluocinolone acetonide intravitreal implant) 0.18 mg is indicated for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye.

Patient 2

13-Month Follow-up After YUTIQ Treatment

Presentation at 13-Month Follow-up

BCVA20/40 -2
IOP15 mmHg
Vitreous cellClear
Fundus exam findingsERM stable
Continue to monitor for IOP elevations and inflammation recurrence.

Imaging at 13-Month Follow-up